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ABSTRACT 
This is a descriptive prospective study conducted in Soba 
University Hospital Feto-Maternal Unit in the period from January to 
October 2002, including 70 women diagnosed as having oligohydramnios. 
The aim was to evaluate the maternal and fetal outcome of the 
pregnancies complicated by oligohydramnios.  
The results reflected that the incidence of pregnancy complications 
was high, (22.86 %) for intrauterine growth restriction (IUGR) and 
hypertension (HTN), while isolated IUGR occurred in  (12.86 %) and 
premature prelabour rupture of membranes (PPROM) in (21.42 %). The rate 
of caesarean section (C/S) was  (60%) and that of emergency caesarean 
section (EM/C/S) was  (55.71%), preterm delivery occurred in  (50 %) of the 
cases. (51.43 %) of the newborns were small for gestational age (SGA). 
Meconium stained amniotic fluid occurred in (11.43%). The overall 
perinatal mortality rate (PNMR) was (14.28%). While the incidence of 
stillbirths  (8.57%). The incidence of congenital anomalies was found to be  
(7.14 %).  
Finally the incidence of neonatal resuscitation and neonatal 
Intensive Care Unit (NICU) admission was found to be   (50 %) in the study 
population.    
  ﻣﻠﺨﺺ  ﺍﻷﻃﺮﻭﺣﺔ
  
ﻫﺫﻩ  ﺩﺭﺍﺴﺔ  ﻭﺼﻔﻴﺔ  ﻤﺴﺘﻘﺒﻠﻴﺔ  ﺘﻤﺕ  ﻓﻲ  ﻤﺴﺘﺸﻔﻰ  ﺴﻭﺒﺎ  ﺍﻟﺠـﺎﻤﻌﻰ  ﻭﺤـﺩﺓ  ﺍﻟﺠﻨـﻴﻥ  ﻭ  
   . ﻡ2002ﺍﻟﺤﻤل  ﺍﻟﺤﺭﺝ  ﻓﻲ  ﺍﻟﻔﺘﺭﺓ  ﻤﻥ  ﻴﻨﺎﻴﺭ  ﺤﺘﻰ  ﺃﻜﺘﻭﺒﺭ 
  ﺤﺎﻟﺔ  ﺘﻡ  ﺘﺸﺨﻴﺼﻬﺎ  ﻜﺤﺎﻻﺕ  ﻟﻨﻘﺹ  ﺍﻟﺴﺎﺌل  ﺍﻻﻤﻨﻴﻭﻨﻲ  07ﺍﺸﺘﻤﻠﺕ  ﻫﺫﻩ  ﺍﻟﺩﺭﺍﺴﺔ  ﻋﻠﻰ  
  .ﺤﻭل  ﺍﻟﺠﻨﻴﻥ 
ﻫﺩﻓﺕ  ﻫﺫﻩ  ﺍﻟﺩﺭﺍﺴﺔ  ﺇﻟﻰ  ﺘﻘﻴﻴﻡ  ﻨﺎﺘﺞ  ﺍﻟﺤﻤل  ﺍﻟﻤﺼﺤﻭﺏ  ﺒﻨﻘـﺼﺎﻥ  ﺍﻟـﺴﺎﺌل  ﺍﻻﻤﻨﻴـﻭﻨﻰ  
  -:ﻜﻤﺎ  ﺍﻨﻌﻜﺴﺕ  ﺍﻟﻨﺘﺎﺌﺞ  ﻓﻲ  ﺍﻵﺘﻲ . ﺍﻟﻤﺘﻤﺜل  ﻓﻲ  ﺍﻷﻡ  ﻭ  ﺍﻟﺠﻨﻴﻥ 
ﻟﺤﺎﻻﺕ  ﺘﺄﺨﺭ  ﻨﻤـﻭ  ﺍﻟﺠﻨـﻴﻥ  %( 68,22) ﻨﺴﺒﺔ  ﺤﺩﻭﺙ  ﻤﻀﺎﻋﻔﺎﺕ  ﺍﻟﺤﻤل  ﺇﻟﻰ ﺍﺭﺘﻔﺎﻉ  
ﺩﺍﺨل  ﺍﻟﺭﺤﻡ  ﻭ  ﺍﺭﺘﻔﺎﻉ  ﻀﻐﻁ  ﺍﻟﺩﻡ  ﺒﻴﻨﻤﺎ  ﻜﺎﻨﺕ  ﻨﺴﺒﺔ  ﺤﺎﻻﺕ  ﺘﺄﺨﺭ  ﻨﻤﻭ  ﺍﻟﺠﻨﻴﻥ  ﺩﺍﺨـل  ﺍﻟـﺭﺤﻡ  
  . ﻟﺤﺎﻻﺕ  ﺘﻤﺯﻕ  ﺍﻷﻏﺸﻴﺔ  ﺤﻭل  ﺍﻟﺠﻨﻴﻥ  ﻏﻴﺭ  ﻜﺎﻤل  ﺍﻟﻨﻤﻭ%(  24,12)ﻭ %( 68,21)ﻓﻘﻁ
ﺒﻴﻨﻤـﺎ  ﻜﺎﻨـﺕ  ﻭﻻﺩﺍﺕ  %( 17,55)ﺍﺀ  ﺍﻟﻌﻤﻠﻴﺎﺕ  ﺍﻟﻘﻴﺼﺭﻴﺔ  ﺍﻟﻤﺴﺘﻌﺠﻠﺔ  ﻜﺎﻨﺕ  ﻨﺴﺒﺔ  ﺇﺠﺭ 
ﻨﺴﺒﺔ  ﺍﻟﻤﻭﺍﻟﻴﺩ  ﺫﻭﻯ  ﺍﻷﻭﺯﺍﻥ  ﺍﻷﻗل  ﻤﻥ  ﻋﻤﺭ  ﺍﻟﺤﻤـل  ﻜﺎﻨـﺕ  %( 05)ﺍﻷﺠﻨﺔ  ﻏﻴﺭ  ﻤﻜﺘﻤﻠﻲ  ﺍﻟﻨﻤﻭ 
ﻤﻥ  ﺍﻟﺤﺎﻻﺕ %(   34,11)ﻨﺴﺒﺔ  ﺼﺒﻎ  ﺍﻟﺴﺎﺌل  ﺍﻻﻤﻨﻴﻭﻨﻰ  ﺒﻌﻘﻰ  ﺍﻟﺠﻨﻴﻥ  ﺤﺩﺜﺕ  ﻓﻲ  %(  . 34,15)
ﺒﻴﻨﻤﺎ  ﻜﺎﻨﺕ  ﻨﺴﺒﺔ  ﺤﺩﻭﺙ  ﺍﻟﺘﺸﻭﻫﺎﺕ  ﺍﻟﺨﻠﻘﻴﺔ  %(  75,8)  ﺓ  ﺍﻷﺠﻨﺔ  ﺩﺍﺨل  ﺍﻟﺭﺤﻡ  ﻜﺎﻨﺕ  ﻨﺴﺒﺔ  ﻭﻓﺎ .
ﺃﺨﻴﺭﺍ  ﻜﺎﻨﺕ  ﻨﺴﺒﺔ  ﺩﺨﻭل  ﺍﻟﻤﻭﺍﻟﻴﺩ  ﺇﻟﻰ  ﻭﺤﺩﺓ ﺍﻟﻌﻨﺎﻴﺔ  ﺍﻟﻤﻜﺜﻔـﺔ ﻟﺤـﺩﻴﺜﻲ  ﺍﻟـﻭﻻﺩﺓ  %(. 41,7)ﻟﻸﺠﻨﺔ 
  %( .05)ﻭﺇﺴﻌﺎﻑ  ﺍﻟﻤﻭﺍﻟﻴﺩ 
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INTRODUCTION 
 
Background:   
The amniotic fluid that bathes the fetus is necessary for proper 
growth and development. It cushions the fetus from physical trauma, permits 
fetal lung growth, and provides a barrier against infection. Normal amniotic 
fluid levels vary, however, the average volume increases with gestational 
age, peaking at 800-1000 ml which coincides with 36-37 weeks gestation. 
The condition of inadequate fluid, oligohydramnios, results in poor 
development of lung tissue and can result in fetal death.(1)                                                          
Pathophysioloyg: 
Amiotic Fluid is primarily produced by fetal urine in the latter half 
of the pregnancy; therefor the absence or reduction of the fetal urine 
production or blockage in the urinary tract can result in oligohydramnios.(2) 
However, rupture of the membranes is the most common cause  of 
oligohydramnios.                                                       
Mortality/Morbidity:  
Using ultrasound, Chamberlin(3) evaluated the perinatal mortality 
rate (PMR) among 7,562 high-risk patients. The PMR of patients with 
normal fluid volumes was 1.97/1000 patients. The PMR increased to 
56.5/1000 in oligohydramnios. The lack of amniotic fluid allows 
compression of the fetal abdomen limiting movement of the diaphragm. 
Minimal movement of the diaphragm and chest wall fixation leads to 
pulmonary hypoplasia. It is also associated with meconium staining of the 
amniotic fluid, fetal heart conduction abnormalities, poor tolerance of labor, 
lower Apgar scores, and fetal acidosis. In cases of intrauterine growth 
restriction (IUGR), the degree of oligohydramnios is often proportional to 
growth restriction and associated with a corresponding increase in the PMR.                        
Measuring amniotic fluid:  
Amniotic fluid volume is evaluated by visually dividing the 
maternal abdomen into 4 quadrants. The largest vertical pocket of fluid is 
measured in centimeters. The total volume is calculated by addition of four 
values. 
Oligohydramnios is defined sonographically as an amniotic fluid 
index(AFI)of less than 8 cm or the absence of a fluid pocket 2-3 cm in 
depth.(4)                         
Causes: 
Fetal urinary tract anomalies,such as renal agenesis, 
polycystic kidneys, or any urinary obstructive lesion 
(eg,posterior urethral valves).  
Maternal problems, including placental vascular 
insufficiency, premature rupture of membranes or chronic 
leakage of amniotic fluid. The major maternal complication 
from this is chorioamnionitis. The incidence of this varies in the 
literature and has been reported anywhere from 21-74%.(1) The 
earlier this occurs in pregnancy causes increased risk to the 
fetus. Thus, increasing the risk of neurologic complications, 
pulmonary hypoplasia and in severe cases, respiratory failure.  
Maternal use of prostaglandin synthase inhibitors or 
angiotensin- converting enzyeme (ACE) inhibitors. Postmaturity 
syndrome in infants when a pregnancy extend beyond 42-
weeks. 
Laboratory Studies: 
Amniotic fluid Lecithin/Sphingomyelin Ratio (L:S) and 
Phosphatidylglycerol (PG) levels are helpful in determining the maturity of 
the developing fetal lungs and,therefore, the likelihood of the development 
of respiratory distress syndrome, if premature delivery is anticipated. 
Test for systemic lupus erythematosus (cuases immune-mediated 
infarcts in the placenta resulting in placental insufficency).                                                        
 
  
Imaging Studies: 
Prenatal ultrasound: Performing  serial measurement of the AFI 
during pregnancy:- If the mother is in the third trimester and the volume is 
less than 8 cm, oligohydramnios is suspected. 
Largest vertical pool of liquor <1- 1.5 cm indicate significant 
oligohygramnios. Visualize the fetal kidneys, collecting system, and bladder; 
if these are normal, suspect chronic leakage of amniotic fluid. Assess fetal 
growth; if urinary tract anomalies or PROM are absent consider possible 
placental insufficiency and IUGR.  
Procedures: 
Transabdominal instillation of indigo carmine may be used to check 
for PROM. Transcervical instillation of normal saline (amnioinfusion), at the 
time of delivery, reduces the risk of cord compression, fetal distress, dilution 
of meconium and the potential need for cesarean delivery. 
Treatment: 
Medical Care:  
The first step is to identify the etiology of the decreased amniotic 
fluid volume. Medical care includes use of steroid to enhance fetal lung 
maturity if preterm delivery is anticipated.  
Maternal bed rest and hydration promote the increase of amniotic 
fluid by increasing the maternal intravascular volume.  
Consultations: 
Maternal fetal medicine in cases of significant oligohydramnios, 
especially when it is associated with congenital malformations. 
Neonatology, genetics, peadiatric surgery and other specialist  
services  are required to care for the infant.         
Further Inpatient Care: 
Consider hospitalizing and thoroughly evaluating the mother in 
cases diagnosed from 26-33 weeks gestation. Delivery should be expedited 
if the biophysical profile is nonreassuring (if fetal anomalies were excluded). 
Instillation of normal saline in the second trimester may benefit some 
patients. In cases associated with postmaturity, review pregnancy dating. If 
true, deliver the fetus either by induction or cesarean section. If meconium is 
present during labor, undertake an amnioinfusion therapy to reduce the 
potential for fetal distress and for prenatal aspiration. 
Complications: 
Lung affection leads to pulmonary hypoplasia, which leads to death 
from severe respiratory insufficiency. Marked deformation of the fetus  
because of intrauterine constraint(Potter syndrome).  
Primary complications are those of fetal distress prior to or during 
labor. Also there is an increased risk of fetal infection in the presence of 
prolonged rupture of the membranes.             
Prognosis: 
In renal agenesis, the mortality is 100%. Milder forms of renal 
dysplasia or obstructive uropathy, however, can be associated with mild-to--
severe forms of pulmoary hypoplasia and long- term renal failure.  The 
efficacy of many treatments in cases of pulmonary hypoplasia, including 
surfactant, high frequency ventilation, and nitric oxide, has not been 
established. The pulmoary prognosis is related to the gestational age at 
which oligohydramnios develops and the amniotic fluid volume.    
 
 
 
 
 
  
 
 
 
 
LITERATURE REVIEW 
Oligohydramnios is a severe and common complication of 
pregnancy that is associated with a poor perinatal outcome.(5)  
Etiologies include congenital anomalies, premature rupture of 
membranes (PROM), intrauterine growth restriction (IUGR), postdatism, 
abruptio placentae, drugs, abnormality of twining, significant maternal 
illness and idiopathic oligohydramnios. 
Sequelae from prolonged oligohydramnios including pulmonary 
hypoplasia and fetal compression syndrome can be devastating. Perinatal 
morbidity and mortality are both significantly increased in pregnancies 
complicated by oligohydramnios.(6)  
Ultrasound detection of oligohydramnios should prompt the 
clinician to thoroughly evaluate the gravida for hypertension and other 
significant illness. In addition, a thorough fetal anatomic survey focusing on 
the genitourinary tract and attempt at visualization of free amniotic bands 
should be performed with ultrasound. Karyotype should be considered. The 
role of amnioinfusion to assist in diagnosis should be considered. Once 
diagnosed, oligohydramnios, with or without associated conditions should 
lead to intensive fetal biophysical surveillance including frequent ultrasound 
evaluation; delivery in the term patient must be considered. The role of 
amnioinfusion as an adjunct to continuous fetal monitoring in labor to 
improve neonatal outcome appears beneficial in selected series.(5)  
David G. Weismiller;(7) Said the two most common applications of 
transcervical amnioinfusion are treatment of severe variable decelerations 
and dilution of thick meconium fluid during pabour.  
 In 1983, Hill-LM; et al(8) concluded that oligohydramnios is a 
hallmark for intrauterine growth restriction (IUGR) and has been evaluated 
in populations suspected of having IUGR. 
They evaluated its incidence in a routine obstetric population. 
During a 16-month period, ultrasound scans were performed in 1,408 
patients. Severe oligohydramnios was identified in six patients (0.43%). 
Two infants had congenital malformations, and 4 had severe IUGR. A subset 
of 317 patients scanned within 2 weeks of delivery was reviewed. Although 
none of the patients fulfilled their original criterion of oligohydramnios 
(absence of a pocket of amniotic fluid 1cm or less in broadest diameter), 
three of 6 small-for-gestational age infants, had a subjective decrease in 
amniotic fluid volume for their stated gestational age. By changing the 
criterion of oligohydramnios to a subjective decrease in amniotic fluid 
volume, the sensitivity of this ultrasonic marker was increased to 50% and 
the specificity to 100%. They believed that the semiquantitative assessment 
of amniotic fluid volume can effectively screened for IUGR and thereby be 
delineated in a population, regardless of the gestational age, that at risk for 
perinatal morbidity and mortality. Eighty pregnancies complicated by 
oligohydramnios constitute the basis for a retrospective study done by 
Shenker-L et al.(9) Forty patients had PROM ; of these , outcomes were good 
in 25. Twelve of 14 fetuses with oligohydramnios and IUGR survived. None 
of the nine fetuses with severe renal anomalies lived. None of the twins with 
twin-twin transfusion syndrome and oligohydramnios survived. Six 
pregnancies with oligohydramnios and premature separation of the placenta 
were identified; all of these resulted in fetal or neonatal death during the 
second trimester. William-K,(10)said amniotic fluid assessment 
is a tool for the evaluation of the fetal well-being, because of the uterine 
cavity being irregular direct evaluation is difficult and subsequently indirect 
techniques have been utilized. The three ultrasound techniques include 1) 
maximum vertical pocket, 2) subjective assessment and 3) amniotic fluid 
index (AFI). All three techniques have been shown to predict peripartum 
morbidity and mortality when they defined decreased amniotic fluid. 
Amniotic fluid volume (AFV) is a week predictor of morbidity and should 
be used in conjunction with other fetal biophysical variables to predict 
perinatal outcome. Youssef AA, et al;(11)said semiquantitative AFV 
determination is a component of fetal biophysical profile  (BPP). TO assess 
decreased AFV they did BPPs of 174 fetuses within one week of delivery. 
Two methods were used, measurement of the single largest vertical pocket 
(oligohydramnios depth <1cm) and the four- quadrants AFI 
(oligohydramnios AFI <5cm). AFV, as determined by each method was 
related to measures of the fetal outcome(perinatal mortality, fetal distress, 
Apgar score, meconium stained amniotic fluid and IUGR ). The AFI was 
more sensitive in predicting mortality (87.5%) and the following measures 
of perinatal morbidity: low 5-minute Apgar score (88.8%), fetal distress 
during labor (86.6%), meconium stained amniotic fluid (63.6%) & the 
presence of IUGR (79.4%). The sensitivity of amniotic fluid pocket 
measurement of <1cm was 75%, 72.2%, 66.6%, 47.7% and 55.8%, 
respectively for the same measures. Their data suggest that qualitative 
measurements of AFV using the AFI is superior to that of the single largest 
pocket in multiple component fetal biophysical testing. In 1989 a sixty-two 
cases of olighydramnios diagnosed by ultrasound between 13-28 weeks 
gestations were reviewed by Three Moore-TR;        et al;(12) experienced  
ultrasonographers used a subjective scale to rate oligohydramnios as mild, 
moderate, severe, or anhydramniotic. Interobserver reliability was excellent 
(intraclass correlation coefficient 0.81). The over all perinatal mortality rate 
was 43%, and the incidence of pulmonary hypoplasia was 33%. One-third 
had lethal congenital anomalies. The frequency of adverse outcome 
correlated strongly with the most severe degrees of oligohydramnios; 88% 
of the fetuses with severe oligohydramnios or anhydramnios had lethal 
outcomes, compared with 11% in the mild/moderate group. The presence of 
an anuric urinary tract anomaly was associated with the most severe grades 
of oligohydramnios and was uniformly fatal .Pulmonary hypoplasia was  
diagnosed in 60% of the severe group versus 6% in the moderate group. 
They concluded that subjective grading of oligohydramnios by experienced 
observers was both reliable and predictive of outcome. The finding of severe 
oligohydramnios in the second trimester was highly predictive of poor fetal 
outcome and should stimulate a thorough search for etiology and 
consideration of intervention. Moderate grades of reduced amniotic fluid 
might be managed with relative optimism.                          
In1986 Sivit CJ; et al (13) reviewed the sonograms of all patients with 
oligohydramnios between 16 and 30 weeks gestation seen over a 4-years 
period to determine:- 
1- Whether sonographically detectable fetal anomalies were present.  
2- When these anomalies were present, how this information was used 
in maternal fetal management.  
Cases of ruptured membranes and fetal demise were excluded from 
the study. Sixteen patients with severe oligohydramnios were identified. On 
postmortem examination, nine had urinary tract anomalies, one had 
evidence of a chronic intrauterine infection, and four had no anomalies. 
There were only two neonatal survivors: one had no anomalies while the 
other had posterior urtheral valves. These findings confirmed that second 
trimester oligohydramnios had a poor prognosis and was often associated 
with anomalies of urinary tract. Sonography aids in the clinical management 
of such patients. Structural pathology and outcome were studied in 170 
chromosomally abnormal fetuses by Wladimiroff JW,(14) referral before 20 
wks gestation was mainly based on fetal structural pathology alone (92%); 
after 20 wks patients were referred because of structural pathology 
combined with small for gestational age and oligohydramnios or 
polyhydramnios .An abnormal AFV was present in 59/170 (34.5%) 
chromosomally affected pregnancy i.e. oligohydramnios in 31 and 
polyhydramnios in 28 cases with poor fetal outcome.  
Mercer-LJ; Brown LG(15) diagnosed thirty-four cases of 
oligohydramnios in the second trimester by ultrasound. Nine of these 
pregnancies were associated with fetal anomalies including Potter syndrome 
(three), atrioventricular dissociation (two), congenital absence of thyroid 
(one), and multiple anomalies (three). There were ten unexplained 
stillbirths, one demise due to abruptio placentae, eight with perinatal 
morbidity after premature labor or abruptio placentae, and six with live- 
born term infants. Although oligohydramnios in the second trimester was 
associated with increased perinatal morbidity, this finding was not 
associated with a  universally poor outcome. 
In 1997 eighteen cases of bladder outlet obstruction were diagnosed 
at Queen Mother’s Hospital(16) over a period of 6 yrs. Commonest cause 
was posterior urtheral valve in 11 cases (61%) oligohydramnios was present 
in (78%) of cases with mortality of (67%) mainly due to pulmonary 
hypoplasia. The six surviving infants (33%) underwent early postnatal 
surgery. Two of these had chronic renal failure on follow up. 
Levine-D; et al;(17) said dolichocephaly was more common in 
preterm fetuses in the breech presentation than those with cephalic 
presentation and was more common in fetuses with  oligohydramnios of 
long duration. Of fetuses in cephalic presentation 10 of 12 (83%) surviving-
dolichocephalic fetuses had respiratory distress syndrome compared with 31 
of 73 (42%) normocephalic fetuses. They concluded that finding of 
dolichocephaly is associated with oligohydramnios of long duration .In 
fetuses with preterm premature rupture of membranes it associated with 
respiratory syndrome; but not otherwise with a poor neonatal prognosis.                                 
In 1984 Barss-VA; et al(18)reported a twelve cases of severe second 
trimester oligohydramnios. The outcome of these pregnancies was 
uniformly poor, with no survivors in the present series. Four patients had 
therapeutic abortions, one woman had spontaneous labor at 22 weeks 
gestation, and seven patients continued to viability. Of these, five patients 
had severe renal anomalies incompatible with life .Two infants died at, or 
shortly after, birth from severe intrauterine growth retardation (IUGR), one 
of which had a triploid karyotype. Review of the literature showed a similar 
poor outcome for pregnancies with severe oligohydramnios in the second 
trimester.  
Wolff-F et al(19) studied complications of oligohydramnios  in 
medical records, of all 5,210 deliveries between 1987 and 1990, 181 cases 
of oligohydramnios were identified. The diagnosis was confirmed by USS 
and based on the method described by Mannings and Platt: AF depots of 
<1cm were defined as oligohydramnios.All 181 met the above definition, 
which resulted in an incidence of 3.5% pregnancies with reduced AF. They 
examined the records of the mother and fetus, the delivery and perinatal 
complications and follow up of the newborn. In more than 60% fetal 
asphyxia, breech presentation and other abnormalities during delivery were 
followed by C/S or vaginal operative delivery by forceps or vaccum 
extractor. In 30 cases oligohydramnios was caused by PROM.In the other 
cases the diagnosis was based on maternal or fetal complication such as 
multiple  gestosis (n=7), abruptio placentae (n=10), fetal growth retardation 
(n=47), and malformations or chromosomal anomalies. Eighty-nine 
newborns were transferred to a paediatric hospital immediately after 
delivery. Potter’s syndrome was the main anticipated diagnosed 
malformations (n=20). The lack of amniotic fluid was furthermore followed 
by a high rate of pulmonary complications such as RDS and hypoplasia of 
the neonatal lung (n=21).  
In conclusion, their study underlined the fact,that oligohydramnios 
must be regarded as an important reason of high risk pregnancy followed by 
many complications for fetus and newborn .The incidence of perinatal 
mortality in their examination was 7.2% this rate was 10 fold higher than in 
the total number of deliveries of their department.  
Golan –A; et al(20) diagnosed 145 cases of oligohydramnios in the 
2nd &3rd trimester  by ultrasonography  out of 25,000 obstetric patients 
(0.58%). In that group, pregnancy complications were  common  such  as 
induced hypertension (22.1%) and bleeding in the 2nd trimester (4.1%). 
They found a high incidence of meconium-stained amniotic fluid (29.1%), 
fetal distress (7.9%) and premature placental separation (4.2%) IUGR 
occurred in (24.5%) of cases. Asphyxia during labor occurred in (11.5%) 
and different other perinatal problems in (23.5%). C/S was performed in 
(35.2%) of these pregnancies .17% of the cases presented as breech. IUFD 
occurred in (5.5%) of these pregnancies. The gross perinatal mortality was 
(16%) and the corrected perinatal mortality was (10.7%). The overall rate of 
fetal malformations was (11%) & that of lethal malformations (4.8%). The 
skeletal (7.6%) and urinary system (4.1%) were predominant systems 
affected. Oligohydramnios was associated with a high rate of pregnancy 
complications and increased fetal morbidity and mortality, thus termination 
should be considered when pulmonary maturity was present or in case of 
fetal distress. 
 In 1990 Lin-CC; et al(21) identified  147 cases of suspected IUGRs 
based on ultrasonic abdominal  circumferences below the 10th percentile, 
56 were confirmed  IUGR infants. Eight of 316 control fetuses with 
abdominal circumference above the 10th percentile turned out to be IUGR 
infants at birth. The incidence of oligohydramnios was strikingly different 
among the three groups: 29% for the IUGR group, 9% for the non-IUGR 
group and 0.6% for the control group (P less than 0.001). When the criteria 
of abdominal circumference below the 10th percentile & the presence of 
oligohydramnios were used together, the positive predictive value doubled 
(from 38.1 to 66.7%; P less than 0,01).                             
Finally there were no significant differences between fetal growth 
retardation with or without oligohydramnios, with respect to maternal risk 
factors or the fetal outcome. They concluded that in fetal growth retardation, 
the occurrence of oligohydramnios during the 3rd trimester of pregnancy 
was not associated with worse fetal outcome.   
In study done by Conway-DL; et al(22) women undergoing labor 
induction for isolated oligohydramnios between37-41/52 gestation were 
matched by gestational age and  parity to women with normal AFI 
measurements who presented in spontaneous labor. Pregnancies complicated 
by hypertension, diabetes, fetal anomalies, or suspected IUGR were 
excluded. The primary outcome variable was route of delivery. Secondary 
outcomes examined included presence of meconium, acidosis, low Apgar 
score and NICU admission. A total of 183 women underwent induction for 
isolated oligohydramnios. When compared to the control group, neonatal 
outcome measures did not differ in the group induced for oligohydramnios. 
However the women who were induced had significantly more C/S 
deliveries (15.8% vs. 6.6%, P<0.01, odds ratio 2.7). The increased need for 
operative delivery was not attributable to more fetal distress in the 
oligohydramnios group. They concluded that  isolated oligohydramnios in 
the otherwise normal term pregnancy may not be a marker for fetal 
compromise; an induction of labor may not be warranted in most cases.  
Hsich TT, et al(23); set  to investigate the perinatal outcome of 
patients with oligohydramnios (AFI <5cm) but without PROM and  
congenital fetal malformations, data from (245) singleton pregnancies were 
analyzed and compared to  those with normal AFVs (5<AFI <24 cm n=27, 
261). Significantly high in incidences of primiparity, PIH, premature 
separation of the placenta, past history of IUFD, past history of preterm 
delivery, postterm pregnancy and advanced maternal age were noticed to be 
associated with occurrence of oligohydramnios. Pregnancies complicated by 
markedly diminished AFV assessed antenataly by ultrasound were 
significantly more frequently associated with adverse perinatal outcomes 
such as preterm delivery, low or very low birth weight, low Apgar scores, 
IUFD, small-for-gestational age newborn, meconium stained amniotic fluid, 
C/S delivery, neonatal intensive care and neonatal death. 
Indomethacin is a non-steroidal anti-inflammatory agent widely 
employed in the treatment of premature contractions. Indomethacin-induced 
oligohydramnios is a well described side effect, and is considered an 
indication for treatment discontinuation. 
 Shen-O, et al(24) presented a case of prolonged anhydramnios, 
secondary to indomethacin therapy with no apparent ill effect on the fetus or 
neonate. 
Los-FJ et al(25)said early 2nd-trimester oligohydramnios was 
associated with normal maternal serum alpha-feto protein (MSAFP) level in 
9 out of 26 cases (35%) of congenital malformations of the fetal urinary tract 
resulting in fetal anuria  were present in 9 cases; in 7 of them normal 
(MSAFP) level, were measured. In contrast, normal (MSAFP) level, were 
established in only 2 out of the 17 cases without fetal malformations. These 
data suggested that fetal urine is the major source of elevated AFP in the 
maternal compartment in early 2nd –trimester oligohydramnios. This is 
further supported by the lack of any relation-ship between concentration of 
MSAFP non-reactive with conccanavalin A, originating mainly from the 
yolk – sac –derived AF pool  (AFP), and the presence of fetal diuresis . 3 out 
of 26 women had experienced early 2nd –trimester oligohydramnios in 
previous pregnancy, suggesting the existence of a recurrence risk for this 
condition. Sarno-AP; et al(26) studied  200 term gravidas  presenting in the 
latent phase of labor with vertex- presenting fetuses. An intrapartum AFI 
<5cm was associated with significant increase in the risk of C/S for fetal 
distress and of an Apgar  score of <7 at one minute as  well as abnormal 
fetal heart rate patterns in late labor, the majority (71.4%) of the patient with 
an intrapartum AFI <5cm had ruptured membranes on entry; however, there 
was no significant difference in outcome when they were compared to 
patients with intact membranes and oligohydramnios. Variable decelerations 
on entry were associated with oligohydramnios in (43.8%) of the patients. 
An AFI <5cm in the early intrapartum period is a risk factor for perinatal 
morbidity and abnormal fetal heart rate patterns in subsequent labor, and 
ruptured membranes in early labor are risk factor for oligohydramnios.                          
Sadovsky-Y, et al(27) tested the hypothesis that patients who have a large 
cord- containing AF pocket will have a lower risk for adverse perinatal 
outcome than women with small cord –containing pocket . Gravidas with an 
antepartum AFI not > 5 cm were studied prospectively. The vertical 
diameter of the single largest cord- containing pocket, which was excluded 
from the calculations of the AFI, was measured.                           
Women of ruptured membranes, multiple gestation, or fetal 
anomalies were excluded. Results of 51 women with gestational age of 35- 
43 weeks were analyzed. Among 35 who had a cord –containing pocket of 
no > 5cm, 8(23%) had fetal distress necessitating operative delivery and 
eight neonates had cord arterial PH below 7.2. None of these complications 
occurred in the16 women who had cord-containing pocket above 5 cm (P 
<0.05). The mean AFI (2.9 versus 2.8 cm ) was not significantly different 
between the groups. Conclusions: Among women with a low AFI, cord –
containing pocket above 5cm identifies a subgroup of women at lower 
perinatal risk  compared with those with smaller cord-containing pocket.  
Van-Reempts P; et al(28) studied neonatal outcome  after very 
prolonged premature rupture of membranes (VPPROM) in 3 categories of  
neonates born before 34/52 gestation: group (1), VPPROM without 
oligohydramnios-(n=28); group (2) VPPROM with oligohydramnios (n=14); 
and group (3), the comparison group without VPPROM (n=39).  
Mortality in group (1) (2 of 28 ) was similar to that in group (2) (6 
of 39 ) and was lower than that in group (2) (5 of 14). Lung hypoplasia and 
limb deformaties were not more frequent in group (1) than in group (3) ( 2of 
28 and 0 of 28 versus 3 of 39 and 1 of 39 respectively) but occurred more 
frequently only in group (2) (5 of 14 and 4 of 14 ).  
All deaths in group (1) and (2) were accounted for by lung 
hypoplasia. There was no difference between the groups for asphyxia, 
(respiratory distress syndrome, air leaks, bronchopulmonary dysplasia, or 
intracranial bleeding. Neonatal infection was more frequent in group (1) (4 
of 14, 28.6%) and group (2) (7 of 28, 25%) when compared with group (3) 
(2 of 39 = 5%).  Within groups (1) & (2) rupture of the membranes was not 
more prolonged in the neonates with infection (median, 9.7 days) compared 
with neonates without infection (median, 9.6 days). In conclusion, when 
VPPROM is not complicated by oligohydramnios, mortality from lung 
hypoplasia and limb deformaties were not more frequent than in control 
neonates of similar gestational age. Bastide –A; et al(29); defined  severe 
oligohydramnios as a condition in which the largest pocket of amniotic fluid  
measures <1cm in its  vertical axis as determined by an ultrasound method , 
was observed in 113 patients  in a population of  15, 431 referred high risk 
patients (0.7%). In all cases, intervention took place unless there was a 
recognized structural anomaly or extreme prematurity. Overall gross 
perinatal mortality was 132.7/1000, and the incidence of major anomaly was 
13.3%. With intervention the corrected perinatal mortality rate was 
17.7/1000, a rate not significantly different from that observed in the entire 
population. All end points of perinatal mortality were significantly increased 
in patients with severe oligohydramnios, in comparison with randomly 
selected control subjects with normal amniotic fluid. These findings were 
interpreted to indicate that severe oligohydramnios in structurally normal 
fetus was an indication for delivery. Van-Dongen-PW; et al(30)did a 
retrospective study to detect the frequency of lethal lung hypoplasia in 48 
cases with prolonged rupture of membranes (> 7 days ) before 34 weeks’ 
gestation.  
Fourteen infants died (29%), but only four deaths (8.3%) were due 
to lung hypoplasia. Three infants with lung hypoplasia had their membranes 
ruptured before 20 weeks gestation and showed echoscopically a persistent 
oligohydramnios, as did the one with rupture  at 26 weeks. Neither the 
duration of rupture of membranes nor the gestational age at the time of 
rupture showed any influence on the occurrence of lung hypoplasia. 
Schrimmer-DB; et al(31)studied prophylactic amnioinfusion as a 
treatment of oligohydramnios in a randomized sample of 305 patients with 
oligohydramnios in labor, 175 patients underwent amnioinfusion with the 
remainder serving as controls. Amniotic fluid was titrated to an AFI >10 cm 
in the treatment group. Patients receiving amnioinfusion had significantly 
less operative intervention for fetal distress (P =0.0001) and fewer C/S (P 
=0.0001). Umblical artery PH at the time of delivery also was increased (P = 
0.0001). Rates of amnionitis and endometritis were not significantly 
different between infused patients and controls. Although the length of 
hospital stay was significantly decreased             (P= 0.002) in the treatment 
group, their data supported earlier reports in the literature that amnioinfusion 
is a useful technique for decreasing intrapartum morbidity for both mother 
and fetus.                                                        Strong TH, et al(32)performed 
amnioinfusion in a prospective, randomized trial of 60 women in the latent 
phase of labor with oligohydramnios  as defined  by AFI < 5cm. All fetuses 
were at least 37 weeks gestation, had  normal baseline fetal heart rate 
variability and no clinically significant fetal heart rate decelerations at the 
outset . Subjects in the amnioinfusion group (n=30) were titrated to and 
maintained at an AFI level  > 8.0 cm throughout labor .In the group 
receiving amnioinfusions significantly lower rates of meconium passage 
(p=0.04), end stage bradycardia (P=0.05), and operative delivery for fetal 
distress (P=0.002) occurred. Significantly higher umblical arterial blood PH 
values were also noticed in the infusion group (P=0.02). They concluded 
that prophylactic intrapartum amnioinfusion is an important technique for 
the reduction of intrapartum morbidity.                                                                                       
 
 
  
 
 
 
 
 
OBJECTIVES 
 
To find out if oligohydramnios is associated with a high incidence 
of adverse pregnancy outcomes including: 
• IUGR, PPROM, HTN, increase rate of C/S, preterm 
delivery, postdatism, small-for-gestational age meconium 
stained amniotic  fluid, still-births, neonatal  resuscitation  
and  NICU  admission. 
•  To assess the association between oligohydramnios and 
the   incidence  of  congenital  anomalies. 
 
  
 
  
 
 
 
 
 
 
PATIENTS AND METHODS 
 
This is a descriptive prospective cross-sectional, 
hospital-based study, carried out in Soba University Hospital 
Feto/Maternal Unit in the period from January to October 2002.                       
The studied population were 70 pregnant women diagnosed in  the  
Feto-Maternal Unit as a cases  of  oligohydramnios  by  three  sonologist 
using  the  same  criterion  for  definition  of  oligohydramnios (presence  of  
amniotic  fluid  largest  vertical  pocket  of  less  than  3  cm  length). The 
patients were followed as an inpatients or outpatients till delivery in the 
same hospital. The fetal outcomes were assessed immediatly after delivery.   
The data collected using questionnaire, Feto-Maternal Uint, labor 
ward records and NICU records. The collected data were coded in a master 
sheet and analyzed by computer.  
 
 
 
 
 
 
 
RESULTS 
Table (1) shows the age distribution of the study population: 
patients between age 25-29 years represented 27.14% of the study 
population and those between 15-19 represented 2.86%.  
Figure  (1) shows that 37.14% were primigravidae, while 42.86% 
were multiparas.                                
Table (2) shows distribution of the gestational age at diagnosis: 
47.14% represented the group 30 to 36 weeks gestation, while those more 
than 40 weeks gestation made up 4.29% of the study population.  Table  (3) 
shows that 70% of the study population had largest vertical pocket of 
amniotic fluid from 1 to 2 cm (moderate degree oligohydramnios), 18.57% 
were mild and 11.43% were less than 1 cm (severe oligohydramnios).            
Table (4) shows distribution of the estimated fetal weight at 
diagnosis. Those between 1 & 2 kg were 42.86% of the study population, 
while estimated weights more than 3 kg represented 5.71%.  
Figure (2) shows ultrasonic assessment of the fetal well being at 
diagnosis: 71.43% had normal well being, while 28.57% were abnormal.  
Table  (5) shows distribution of abnormal fetal well being among 
the study population, 50% of them had poor BPP, 15% had pathological 
CTG and 35% had an abnormal  "Doppler".  
 Figure  (3) shows presence of pregnancy complications among the 
study population: 77.14% had pregnancy complications, while 22.86% of 
the study population had no complications.   
Table  (6) shows that 22.86% had IUGR  & HTN, 21.43% had 
PPROM. Other complications including APH represent 4.28% of the study 
population.  
Table  (7) shows that 50% of the outcome were preterm, 40% were 
term and 10% were postterm.  
Table  (8) shows distribution of the study population according to 
the mode of delivery: 55.71% delivered by EM/C/S, while 28.57% 
underwent SNVD.  
Table  (9) shows that 30.77% of EM/C/S were done for poor BPP, 
23.08% for pathological Cogs and 15.38% for an abnormal Doppler scans.   
Concerning the living status of the outcome shown by table (10): 
91.43% were born alive, 5.71% were MSB and 2.86% of the outcomes were 
FSB and another 5.71% for the END. The overall PNMR represented 
14.28% of the study population. 
 Figure  (4) shows that 37.14% of the study population gave birth to 
male babies, 61.43% gave birth to female babies, and one case had an 
undifferentiated sex.  
Table  (11) shows weight distribution of the outcomes: 48.57% of 
the study population were between 1 & 2 kg, 8.57% were less than 1 kg, 
while those weighs more than 3 kg were 5.72% of the study population.  
Figure  (5) shows the percentile chart assessment of the outcome 
(wt/GA): 51.43% of the outcomes were SGA, while one case was LGA.  
Table (12) shows that 50% of the outcomes needed resuscitation 
and NICU admission.   
Figure  (6) shows that 11.43% had meconium stained amniotic 
fluid.  
Figure (7) shows that the incidence of congenital anomalies was 
7.14% among the study population, while the details and distribution of 
anomalies is shown in table (13), 20% for each anomaly.  
Table (14) shows that there is a significant association between the 
severity of oligohydramnios and the outcome in form of resuscitation and 
NICU admission.  
Table  (15) shows that there is no significant association between 
the degree of oligohydramnios and the mode of delivery. 
 
 
 
 
 
 
 
Table 1: Distribution of Studied Population According to Age 
% No. of Patients Age (in years ) 
2.86 2 15 _______ 19 
18.57 13 20 _______ 24 
27.14 19 25 _______  29 
21.43 15 30 _______ 34 
22.86 16 35 _______ 39 
7.14 5 40 &>40 
100.00 70 Total 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2: Distribution of Gestational Age at Diagnosis  
% No. of Patients Gestational Age (in weeks) 
15.71 11 < 30 
47.14 33 30_______ 36 
32.86 23 37_______ 40 
4.29 3 >40 
100.00 70 Total 
   
 
 
 
 
 
 
 
 
 
 
  
 
Table 3: Distribution of Amniotic Fluid Assessment 
 (largest vertical pocket)   
% No. of Patients Largest vertical pocket (cm) 
11.43 8 <1 
70.00 49 1_______ 2 
18.57 13 2.1_____ 2.9 
100.00 70 Total 
            
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Table 4: Distribution of Ultrasonic Estimation of The Fetal weight  
at Diagnosis  
% No. of Patients Weight in Kg 
15.71 11 <1 
42.86 30 1_________ 2 
35.72 25 2.1________3 
5.71 4 >3 
100.00 70 Total 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Table 5: Types of Abnormal Fetal Well-Being   
% No. of Patients Abnormal Fetal Well-Being
50 10 Poor Biophysical Profile 
15 3 Pathological CTG 
35 7 Abnormal Doppler US 
100.00 20 Total 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Table 6: Distribution of Pregnancy Complications  
% No. of Patients Types of Complications 
22.86 16 Oligo-without Complications 
22.86 16 IUGR & HTN 
12.86 9 IUGR 
21.43 15 PPROM 
8.57 6 HTN 
2.86 2 IUGR &Others 
1.42 1 PPROM & Others 
2.86 2 PPROM & IUGR 
4.28 3 Others 
100.00 70 Total 
 
 
 
 
 
  
 
 
 
Table 7: Distribution of Gestational Age at Delivery 
% No. of  Patients Gestational age (weeks) 
50 35 Preterm       (< 37) 
40 28 Term          ( 37_____  42)
10 7 Postterm      ( >42) 
100 70 Total 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8: Distribution According to Mode of Delivery 
% No. of Patients Mode of delivery 
28.57 20 Spontaneous vaginal delivery 
10.00 7 Induced vaginal delivery 
1.43 1 Instrumental vaginal delivery 
55.71 39  EM/C/S 
4.29 3 EL/C/S 
100.00 70 Total 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9: Indication for emergency caeserean section 
% No. of Patients Indication 
30.77 12 Poor BPP 
23.08 9 Pathological CTG 
15.38 6 Abnormal doppler 
10.27 4 High BP 
7.69 3 Fetal Distress 
2.56 1 APH 
2.56 1 IUGR 
7.69 3 Repeated C/S in Labor 
100.00 39 Total 
 
 
 
 
 
 
 
 
 
 
 Table 10: Distribution of The Outcome According to the  
Living status 
% No. of Patients The Outcome 
91.43 64 Alive 
5.71 4 MSB 
2.86 2 FSB 
100.00 70 Total 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Table 11: Weight Distribution of The Outcome  
% No. of Patients Weight (kg) 
8.57 6 <1 
48.57 34 1_______ 2 
37.14 26 2.1______3 
5.72 4 >3 
100.00 70 Total 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Table 12: Distribution of The Outcome According to NICU admission 
and Resuscitation    
% No. of Patients Status of NICU admission and 
Resuscitation 
50.00 32 Resuscitated and admitted  toNICU 
46.88 30 Neither resuscitated nor admitted 
3.12 2 Resuscitated but not admitted 
100.00 64 Total 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Table 13: Distribution of Congenital Anomalies 
% No. of  Patients Types of Anomalies 
20.00 1 Exomphalus 
20.00 1 Infantile Polycystic Kidney 
20.00 1 Prune Belly Syndrome 
20.00 1 Posterior Urethral Valve 
20.00 1 Ascites 
100.00 5 Total 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 14:Cِrosstabulation: Severity of Oligohydramnios and Living 
Outcome 
P. ValueA & not B Not A or B A & B Degree of 
Oligohydramnios 
- % No % No % No No - 
0.04 - - 20 1 80 4 5 1 
0.000 - - 45.65 21 54.3525 46 2 
0.003 15.382 61.54 8 23.083 13 3 
  2  30  32 64 Total 
 
A=  Resuscitated 
B=  Admitted to NICU 
 
 
 
 
 
 
 
 
 
Table 15: Crosstabulation: Degree of Oligohydramnios and The Mode 
of Delivery   
Total C/S Vaginal delivery Degree of 
Oligohydramnios 
% % No. % No. No. - 
100 50 4 50 4 8 1 
100 65.3 32 34.7 17 49 2 
100 46.15 6 53.85 7 13 3 
100 60 42 40 28 70 Total 
1- Severe  
2- Moderate 
3- Mild 
(P =  0.3778) 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 
Soba University Hospital as a tertiary care hospital receives a 
considerable load from allover the Sudan, especially those considered to be 
high-risk patients. 
We studied 70 cases of oligohydramnios diagnosed at Soba 
University Hospital/Feto-Maternal Unit.  We followed them till delivery. 
There were high rates of adverse pregnancies outcome .The 
perinatal mortality rate in the hospital during the study period was 4%, in the 
study group this was increased to 14.28%.   This is clearly due to the adverse 
effects of oligohydramnios  .In the study done by Golan - A; et al, (20) the 
PNMR was found to be 16% and this almost goes with our rate 22.86 % of 
the studied population showed isolated oligohydramnios, while the same 
percentage had an IUGR and HTN together. 12.86 % had only IUGR, while 
21.43 % had PPROM. Other complication including APH represented by 
4.28 % of the studied population.   
In 1991 Shenker –L(9) studied 80  pregnancies  complicated  by  
oligohydramnios  and obtained  the  following  results , 50 %   had  PPROM, 
17.5 %   had  an  IUGR  and   7.5 %   had  premature   
Separation of the placenta.  Another study by Wolff-F (19) in 1994, of 181 
cases of oligohydramnios 16.57 % had PPROM, 25.96 % had an IUGR and  
(5.52 %) had abruptio placentae  .In the same year Golan-A (20) studied 145 
cases of oligohydramnios, pregnancy induced hypertension was found in 
22.1 %, premature separation of the placenta in 4.2 % and an IUGR occurred 
in 24.5% of the studied  
 Population.  The rate of C/S in the hospital during the study period 
was 38% and this rate is due to the increasing number of referrals from the 
other hospitals. The surprising rate of C/S in this study 60 % reflects the 
high incidence of fetal compromise the overall incidence of EM/C/S was 
55.71%, of these 30.77% had poor biophysical profiles, 23.08% had 
pathological CTGs and 15.38% had abnormal Doppler scans. This high rate 
of C/S is almost twice the incidence of C/S in the study done by Goal. A(20),     
which  was  35.2% . The incidence of instrumental deliveries in the hospital 
during that period was 2%, while in our study we found it to be 1.43% 
without any significant increase and this may be due to increase in the C/S 
rate and prematurity. 40 % of the deliveries were term, 10% poster and the 
remaining 50% were preterm.  The high incidence of preterm deliveries 
explains the fact that 50% of the babies needed resuscitation and NICU 
admission.   
The rate of NICU admission in the hospital at that time was 20.76% 
and quarter of them was resuscitated.  In the study done by Wolff –F (19) 
49.17 % of the newborns were transferred to a paediatric hospital 
immediately after delivery. Among the study population 11.43 % had 
meconium stained amniotic fluid, while the percentage was 29.1 % in the 
study done by Golan. A(15) and this difference may be due to premature 
intervention due to inefficient intrapartum monitoring. Congenital anomalies 
showed an incidence of 0.5% in the hospital population, while 7.14% was 
the incidence among the study population. Congenital anomalies as a cause 
of oligohydramnios may be the reason for this increase in the rate.  
In  1986 Bastide A(29) studied 113  cases  of  oligohydramnios  ,  
and    congenital  anomalies  were  found    in  13.3 %   of  them  .  In the 
same year Mercer L (15) studied 34 cases of oligohydramnios and found 26.4  
% had congenital anomalies.  
Lastly Wolff – F(19) found that  the  incidence  of  congenital  
anomalies   was  11.04 %  , which  was  almost  similar  to  that  studied  by  
Golan. A(20); (11%) .The high  incidence  of  congenital  anomalies  in  the  
other  studies  may  be  due  to  the  good   
Antenatal screening. 
In this study there is a significant association between the severity 
of oligohydramnios and the outcome in the term of neonatal resuscitation 
and NICU admission  (P values  < 0.05), but there is no significant relation 
between the severity of oligohydramnios and the mode of delivery. 
  
CONCLUSION 
 
Oligohydramnios was found to be a high-risk pregnancy in term of 
increased incidence of adverse pregnancy outcome and association with 
congenital anomalies. The incidence of adverse pregnancy outcomes as 
follows: 
• IUGR and Hypertension 22.86%, IUGR alone 12.86%, and PPROM 
were 21.42% of the studied population. 
• The rate of C/S was 60% and emergency cesarean section was found 
to be 55.71%.  
•  Preterm delivery occurred in 50%, while 10% of the cases were 
postterm.   
•  51.43% of the newborn were small-for-gestational age.  
•  Meconium stained amniotic fluid occurred in 11.43%.  
• The incidence of neonatal resuscitation and NICU admission was 
50%.  
•  The overall PNMR was 14.28% and the incidence of stillbirths was 
8.57%.                                  
• 7.14% of the outcome had congenital anomalies.  
• There is a significant association between the severity of 
oligohydramnios and fetal outcome in term of neonatal resuscitation and 
NICU admission (P values 0.04, 0.00, and 0.003 for severe, moderate and 
mild respectively.)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
RECOMMENDATIONS 
 
• To  reduce  the  incidence  of  the  adverse pregnancy  outcome  
concerning  the  mother  and  the  fetus we recommend  the  following:- 
•  Early detection by referring the suspected cases to be manages in 
tertiary hospitals with a well-equipped Obstetrics and Neonatal 
Departments. 
•  Pediatric surgeons should be involved in cases, which need surgical 
intervention.  
• Amnioinfusion has to be tried as it has a role in the diagnosis and 
treatment of oligohydramnios.  
• Increasing the number of special centers to improve the outcome. 
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